๐Ÿ›๏ธ Verified NIH Record โ€ข Updated 2026-04-06

Exercise and Soft Tissue Sarcoma (NCT04921917)

๐ŸŸข Recruiting Observational / Diagnostic ๐Ÿ“‹ Clinical Research Protocol Sponsor: Duke University

๐Ÿฉบ Plain-English Summary (8th-Grade Level)

The purpose of this study is to evaluate the effect of a neoadjuvant (i.e. pre-treatment) exercise regimen on extremity function and postoperative wound healing. The study group will include patients with a primary diagnosis of soft tissue sarcoma undergoing treatment with neoadjuvant radiation therapy and surgical resection. Patients with upper or lower extremity sarcomas will be considered for enrollment.

Who can join: To join this study, participants generally need to meet the listed inclusion criteria (13 items) and avoid the listed exclusions (18 items).

Location: Duke University โ€” Durham, North Carolina

๐Ÿ“‹ "Do I Qualify?" โ€” 1-Minute Self Screener

Instant Checklist

Check every box below. If you can check all of them, you may meet the study's basic screening requirements (final eligibility is confirmed by the site team).

Usually NOT eligible if any of the following apply:

  • Exclusion Criteria:
  • Patients under the age of 18, or over the age of 85
  • Treatment plan that does not include neo-adjuvant radiation and surgical excision
  • Sarcoma location other than the upper or lower extremity
  • History of radiation therapy to the tumor and/or surgical area prior to the current treatment being studied
  • High dose steroid therapy (defined as \>5mg prednisone, or equivalent, with the last 30 days)
  • Active treatment with chemotherapy within the last 30 days
  • Inability of the patient to provide informed consent (i.e. dementia, cognitive impairment, non-English speakers)
  • Plan for post-operative radiation therapy
  • Underlying severe cardiopulmonary disease
  • Prior surgery, other than a biopsy, at the site of disease
  • Tumors that are ulcerative or fungating through the dermis at the time of presentation

๐Ÿ” Extracted verbatim from the official NIH eligibility criteria. Always confirm with the study coordinator.

๐Ÿ“ All Participating Trial Locations (1 Sites)

  • Duke University โ€” Durham, North Carolina

๐Ÿ’ฐ Cost, Insurance & Patient Rights

  • 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
  • Routine Patient Care: Under federal law (ACA ยง 2709) and many state statutes, routine care costs are covered during participation.
  • Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
๐Ÿ›๏ธ View Official NIH Record โ†—